We acknowledge that the study is limited by the use of a small number of cases; however, it forms a platform for a deeper understanding of α-synuclein modifications and their pathological relevance in two key α-synucleinopathies: IPD and MSA. The gene discussed is SNCA; the disease is multiple system atrophy.